BrokerLens

Molbio Diagnostics Limited IPO (MOLBIO)

Status
Listed
Security type
Mainboard
Price band
Rs.768 to Rs.807
Final issue price
Rs 807
Issue size
Not disclosed
Bidding opens
10 August 2026
Bidding closes
12 August 2026
Listing date
17 August 2026

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Molbio Diagnostics Limited IPO?

The Molbio Diagnostics Limited IPO price band is Rs.768 to Rs.807 per share.

When does the Molbio Diagnostics Limited IPO open and close?

Bidding opens 10 August 2026 and closes 12 August 2026.

Is the Molbio Diagnostics Limited IPO a mainboard or SME issue?

Molbio Diagnostics Limited is a mainboard IPO, listing on NSE's main board.

When did the Molbio Diagnostics Limited IPO list?

Molbio Diagnostics Limited listed on 17 August 2026.

Does this page show the grey market premium (GMP) for Molbio Diagnostics Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Molbio Diagnostics Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.